AHK-Cu (Copper Tripeptide)

InvestigationalSkin And Cosmetic ResearchSkin & hair
6.5

Worth trying, BioHarmony verdict

BioHarmony score 6.5 out of 10

AHK-Cu is a topical copper tripeptide, Alanine-Histidine-Lysine plus copper, marketed for hair growth. Its entire AHK-Cu-specific evidence base is one unreplicated in-vitro study from 2007, per Pyo, with no human trial. It is harmless as a cosmetic but barely studied.

Read full report

What is AHK-Cu (Copper Tripeptide)?

AHK-Cu is a synthetic copper-binding tripeptide, the amino acids Alanine, Histidine, and Lysine carrying a copper ion, sold mostly as a topical cosmetic for hair growth. Think of it as the lesser-known cousin of GHK-Cu: the two molecules differ by a single amino acid, yet their evidence bases are not even close. The proposed logic is targeted copper delivery to skin and follicle tissue, where copper helps cross-link collagen and elastin and where the peptide is said to raise VEGF and wake up the dermal-papilla cells that drive follicle growth, per Pyo 2007. That story is coherent.

From the BioHarmony report, reviewed Sep 8, 2026.

Saved on this device only.

How it is thought to work

Targeted copper delivery to skin and follicle tissue, with proposed VEGF and dermal-papilla stimulation

Safety watch-outs

  • Persistent or spreading scalp rash, swelling, or contact dermatitis: stop applying and let the skin recover.
  • Anyone considering injectable or mesotherapy use: it is off-label, non-approved, and unstudied for AHK-Cu
  • do not inject.

Full risk profile in the BioHarmony report.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

No approved-label or study protocol is recorded for AHK-Cu (Copper Tripeptide) yet.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalInvestigational
CompoundingEligibility not established.

AHK-Cu has ex vivo human hair-follicle and cultured dermal-papilla-cell research. That laboratory evidence does not establish clinical effectiveness, injectable use, or an FDA-approved hair-loss treatment.

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.